| | Dear Dr Wirawan,
We are pleased to share with you our March content update, featuring journal news, top articles and our most recent table of contents.
Featured Collection In recognition of World TB Day 2016, BMC Medicine and BMC Infectious Diseases have launched an article collection. In collaboration with the UCL-TB Centre and the LSHTM TB Centre, guest edited by Ibrahim Abubakar, Helen Fletcher, Marc Lipman and Tim McHugh. The collection includes articles addressing the most up-to-date evidence and innovation in the diagnosis, management and prevention of TB, as well as particular challenges affecting vulnerable populations.
From the BMC Medicine blog  |
| Reported discrepancies between the information provided when the trial is registered and the data reported in publications is becoming a hot topic - especially with regards to outcome switching in randomised controlled trials. Updating the clinical trial record could be that missing link that differentiates between selective reporting and transparency of research. |
 |
| Every year on 24th March, World TB Day aims to raise awareness about the disease, and this year focuses on ending TB through collaborative efforts. In recognition of this, we launched a new article collection, guest edited by leading TB researchers from UCL and LSHTM, which highlights some of the latest findings and debates in TB research. |
 |
| David Moore, author of research published in BMC Medicine's tuberculosis series, talks of how new research tools could help towards eradicating tuberculosis. This blog was originally posted on the London School of Hygiene & Tropical Medicine's website. |
Table of Contents Commentary
Correspondence | TIME Impact – a new user-friendly tuberculosis (TB) model to inform TB policy decisions | | R. M. G. J. Houben, M. Lalli, T. Sumner, M. Hamilton, D. Pedrazzoli, F. Bonsu, P. Hippner, Y. Pillay, M. Kimerling, S. Ahmedov, C. Pretorius and R. G. White | | BMC Medicine 2016, 14:56 |
Editorial
Opinion
Question and answer
Research | Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial | | Bronner P. Gonçalves, Alfred B. Tiono, Alphonse Ouédraogo, Wamdaogo M. Guelbéogo, John Bradley, Issa Nebie, Débé Siaka, Kjerstin Lanke, Alice C. Eziefula, Amidou Diarra, Helmi Pett, Edith C. Bougouma, Sodiomon B. Sirima, Chris Drakeley and Teun Bousema | | BMC Medicine 2016, 14:40 |
| Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy | | Angela M. Crook, Anna Turkova, Victor Musiime, Mutsa Bwakura-Dangarembizi, Sabrina Bakeera-Kitaka, Patricia Nahirya-Ntege, Margaret Thomason, Peter Mugyenyi, Philippa Musoke, Adeodata Kekitiinwa, Paula Munderi, Kusum Nathoo, Andrew J. Prendergast, A. Sarah Walker and Diana M. Gibb | | BMC Medicine 2016, 14:50 |
| A new trial design to accelerate tuberculosis drug development: the Phase IIC Selection Trial with Extended Post-treatment follow-up (STEP) | | Patrick P. J. Phillips, Kelly E. Dooley, Stephen H. Gillespie, Norbert Heinrich, Jason E. Stout, Payam Nahid, Andreas H. Diacon, Rob E. Aarnoutse, Gibson S. Kibiki, Martin J. Boeree and Michael Hoelscher | | BMC Medicine 2016, 14:51 |
| Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance | | Jody Phelan, Francesc Coll, Ruth McNerney, David B. Ascher, Douglas E. V. Pires, Nick Furnham, Nele Coeck, Grant A. Hill-Cawthorne, Mridul B. Nair, Kim Mallard, Andrew Ramsay, Susana Campino, Martin L. Hibberd, Arnab Pain, Leen Rigouts and Taane G. Clark | | BMC Medicine 2016, 14:31 |
| Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration | | Caroline A. Sabin, Peter Reiss, Lene Ryom, Andrew N. Phillips, Rainer Weber, Matthew Law, Eric Fontas, Amanda Mocroft, Stephane de Wit, Colette Smith, Francois Dabis, Antonella d'Arminio Monforte, Wafaa El-Sadr and Jens D. Lundgren | | BMC Medicine 2016, 14:61 |
Review
Benefits of Publishing With Us | • | 2015 median turnover times: initial decision three days; first decision after peer review 40 days | | • | Portable peer review | | • | Broad medical readership | Follow @BMCMedicine on Twitter | | | |
